State of Alaska Department of Revenue’s Albany Molecular Research Inc AMRI Stock Holding History

State of Alaska Department of Revenue’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,357	Closed	-$94K	–	1298
2017 Q2	$94K	Buy	4,357 +1,947	+81%	+$35.3K	0.01%	1118
2017 Q1	$33K	Hold	2,410	–	–	﹤0.01%	1169
2016 Q4	$45K	Buy	+2,410	New	+$41K	﹤0.01%	850

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

State of Alaska Department of Revenue's AMRI Position: Q3 2017 in Review

State of Alaska Department of Revenue sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 4,357 shares — an estimated $94K sold.

State of Alaska Department of Revenue first reported a position in AMRI in Q4 2016 and held it in 3 quarters. The position peaked at $94K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

State of Alaska Department of Revenue reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
State of Alaska Department of Revenue sold 4,357 Albany Molecular Research Inc shares in Q3 2017, an estimated $94K.
State of Alaska Department of Revenue first reported a position in Albany Molecular Research Inc in Q4 2016 and held it in 3 quarters.
State of Alaska Department of Revenue's Albany Molecular Research Inc position peaked at $94K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2017, filed 16 Oct 2017.